Tick-Borne mystery: french study aims to uncover hidden cases of babesiosis
NCT ID NCT07345988
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at 100 cases of human babesiosis, a rare tick-borne disease, diagnosed in France between 2000 and 2024. Researchers want to describe who gets it, what symptoms they have, and how they are treated. The goal is to improve recognition and care, especially for vulnerable people like those with weak immune systems or no spleen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors recognize and treat babesiosis earlier, potentially reducing severe outcomes in high-risk patients.
- What could go wrong
- This is an observational study that only looks back at past cases, so it cannot prove what treatments work best. The number of cases may be too small to draw firm conclusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN BABESIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre de référence des maladies vectorielles à tiques, CNR Borrelia - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France